Ulf Meier-Kriesche

Dr. Ulf Meier-Kriesche has a strong background in medicine, with extensive experience in clinical trials and medical leadership roles. Ulf has held positions at various prestigious institutions, including the University of Florida, University of Michigan, and The University of Texas Health Science Center at Houston. Dr. Meier-Kriesche has also contributed to the pharmaceutical industry, serving as the Chief Scientific Officer at Veloxis Pharmaceuticals and holding various roles at Bristol-Myers Squibb and Astellas Pharma. Their expertise spans across immunology, outcomes research, and transplant medicine.

Ulf Meier-Kriesche, MD began their education journey by earning their Doctor of Medicine (MD) degree in Medicine from the University of Perugia, where they studied from 1985 to 1992. Following this, they pursued a Specialty board in Nephrology at the Università degli Studi di Cagliari from 1992 to 1996.